Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission
The Food and Drug Administration (FDA, Agency, or we) is issuing a final rule to require electronic submission of certain postmarketing safety reports for approved new animal drugs. The final rule also provides a procedure for requesting a temporary waiver of the electronic submission requirement.
Regulatory Impact Analysis
Federal Register: 21 CFR Part 514, July 29, 2020
Docket: FDA-2017-N-6381